canada clinical guidance

Acute coronary syndromes: suspected ACS triage + post-discharge GP checklist

A Canadian clinical summary of acute coronary syndromes: suspected acs triage + post-discharge gp checklist, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by 2020 acute coronary syndromes guidelines. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CCS ACS

Source-attributed clinical priorities

  • Obtain an ECG rapidly and use serial high-sensitivity troponin within an approved local algorithm.
  • Treat ongoing ischemia or hemodynamic or electrical instability as an emergency requiring immediate specialist coordination.
  • At discharge, reconcile antithrombotic therapy, secondary prevention, rehabilitation and follow-up, documenting intended durations.
  • Arrange cardiac rehabilitation and secondary prevention before discharge, not as an optional later add-on.
sources for this section:CCS ACS

Practical assessment and management workflow

1
Record symptom onset, ECG and serial troponin and establish bleeding and ischemic risk.
2
Give syndrome-appropriate antiplatelet and anticoagulant therapy while coordinating invasive assessment.
3
Treat complications including arrhythmia, heart failure, recurrent ischemia and mechanical instability.
4
At discharge, document antithrombotic duration, lipid treatment, rehabilitation and early follow-up.
sources for this section:CCS ACS

Safety, red flags and urgent escalation

  • Escalate shock, refractory pain, malignant arrhythmia or dynamic ST elevation immediately.
  • Balance thrombosis and bleeding when combining anticoagulant and antiplatelet medicines.
  • Do not stop dual antiplatelet therapy after stenting without urgent cardiology discussion.
sources for this section:CCS ACS

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CCS ACS

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CCS ACS

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Canadian Cardiovascular Society2020 acute coronary syndromes guidelinesaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.